127 related articles for article (PubMed ID: 15683422)
1. Changes in serum lipid concentrations in patients with chronic hepatitis C virus positive hepatitis responsive or non-responsive to interferon therapy.
Hamamoto S; Uchida Y; Wada T; Moritani M; Sato S; Hamamoto N; Ishihara S; Watanabe M; Kinoshita Y
J Gastroenterol Hepatol; 2005 Feb; 20(2):204-8. PubMed ID: 15683422
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between the level of serum TNF-alpha of patients with chronic hepatitis C and treatment with interferon-alpha and the influencing factors].
Ren Y; Duan ZH; Meng QH; Li Z; Li J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):129-31. PubMed ID: 20104757
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between diversity of hepatitis C virus quasispecies and viremia, activity of liver disease and response to interferon therapy].
Tang X; Qian K; Yuan X; Johnson YN
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):128-31. PubMed ID: 12196822
[TBL] [Abstract][Full Text] [Related]
4. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
Xu DZ; Xie Y; Li ZQ
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
[TBL] [Abstract][Full Text] [Related]
5. Serum interleukin 6 concentrations in chronic hepatitis C patients before and after interferon-alpha treatment.
Malaguarnera M; Di Fazio I; Laurino A; Ferlito L; Romano M; Trovato BA
Int J Clin Pharmacol Ther; 1997 Sep; 35(9):385-8. PubMed ID: 9314092
[TBL] [Abstract][Full Text] [Related]
6. Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C.
Naeem M; Bacon BR; Mistry B; Britton RS; Di Bisceglie AM
Am J Gastroenterol; 2001 Aug; 96(8):2468-72. PubMed ID: 11513192
[TBL] [Abstract][Full Text] [Related]
7. State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin.
Jurczyk K; Karpińska E; Wawrzynowicz-Syczewska M; Morańska I; Noceń I; Chlubek D; Boroń-Kaczmarska A
Hepatogastroenterology; 2008; 55(82-83):557-61. PubMed ID: 18613407
[TBL] [Abstract][Full Text] [Related]
8. A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy.
Annicchiarico BE; Siciliano M; Avolio AW; Grillo RL; Bombardieri G
Aliment Pharmacol Ther; 2007 May; 25(9):1039-46. PubMed ID: 17439504
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
Grüngreiff K; Reinhold D; Ansorge S
Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
[TBL] [Abstract][Full Text] [Related]
10. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
[TBL] [Abstract][Full Text] [Related]
11. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
12. [Changes of lipid metabolism in patients with chronic viral hepatitis treated with interferon alpha].
Zejc-Bajsarowicz M; Cieśla A; Mach T; Janas-Skulina U; Warunek W; Zyrkowska-Bieda T
Przegl Lek; 2005; 62(4):214-7. PubMed ID: 16229237
[TBL] [Abstract][Full Text] [Related]
13. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
15. Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1,386-patient study from Taiwan.
Huang JF; Yu ML; Lee CM; Dai CY; Hou NJ; Hsieh MY; Wang JH; Lu SN; Sheen IS; Lin SM; Chuang WL; Liaw YF
Aliment Pharmacol Ther; 2007 May; 25(9):1029-37. PubMed ID: 17439503
[TBL] [Abstract][Full Text] [Related]
16. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.
Fujita N; Kaito M; Kai M; Sugimoto R; Tanaka H; Horiike S; Konishi M; Iwasa M; Watanabe S; Adachi Y
J Viral Hepat; 2006 Jul; 13(7):441-8. PubMed ID: 16792537
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of chronic hepatitis C treatment in hemophilic patients.
Husa P; Roznovsky L; Smejkal P; Husova L; Penka M; Dite P
Hepatogastroenterology; 2005; 52(65):1541-4. PubMed ID: 16201114
[TBL] [Abstract][Full Text] [Related]
18. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
[TBL] [Abstract][Full Text] [Related]
19. Role of nitric oxide (NO) in interferon-alpha therapy for hepatitis C.
Hokari A; Zeniya M; Esumi H; Ishikawa T; Kurasima Y; Toda G
J Infect; 2005 Jul; 51(1):47-53. PubMed ID: 15979491
[TBL] [Abstract][Full Text] [Related]
20. Baseline cholesterol is associated with the response to antiviral therapy in chronic hepatitis C.
Economou M; Milionis H; Filis S; Baltayiannis G; Christou L; Elisaf M; Tsianos E
J Gastroenterol Hepatol; 2008 Apr; 23(4):586-91. PubMed ID: 17498221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
